Drugs / CSL Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01591837 | May → Jun 2012 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01591837 ↗ |
| Modality | Vaccine | “The study vaccine (CSL Influenza Vaccine)” NCT01591837 ↗ |
| Route | Intramuscular | “The vaccine will be administered by intramuscular or subcutaneous injection.” NCT01591837 ↗ |
| Route | Subcutaneous | “The vaccine will be administered by intramuscular or subcutaneous injection.” NCT01591837 ↗ |